全文获取类型
收费全文 | 52614篇 |
免费 | 7784篇 |
国内免费 | 584篇 |
专业分类
耳鼻咽喉 | 1256篇 |
儿科学 | 1127篇 |
妇产科学 | 1367篇 |
基础医学 | 4769篇 |
口腔科学 | 3122篇 |
临床医学 | 6700篇 |
内科学 | 12207篇 |
皮肤病学 | 1410篇 |
神经病学 | 3958篇 |
特种医学 | 2599篇 |
外科学 | 7964篇 |
综合类 | 581篇 |
现状与发展 | 12篇 |
一般理论 | 15篇 |
预防医学 | 3974篇 |
眼科学 | 1241篇 |
药学 | 2933篇 |
中国医学 | 345篇 |
肿瘤学 | 5402篇 |
出版年
2024年 | 174篇 |
2023年 | 1291篇 |
2022年 | 923篇 |
2021年 | 1610篇 |
2020年 | 1702篇 |
2019年 | 1287篇 |
2018年 | 2254篇 |
2017年 | 1943篇 |
2016年 | 2384篇 |
2015年 | 2773篇 |
2014年 | 3392篇 |
2013年 | 4012篇 |
2012年 | 3189篇 |
2011年 | 3228篇 |
2010年 | 2842篇 |
2009年 | 3222篇 |
2008年 | 2565篇 |
2007年 | 2233篇 |
2006年 | 2214篇 |
2005年 | 1959篇 |
2004年 | 1586篇 |
2003年 | 1520篇 |
2002年 | 1369篇 |
2001年 | 1130篇 |
2000年 | 947篇 |
1999年 | 1010篇 |
1998年 | 744篇 |
1997年 | 706篇 |
1996年 | 727篇 |
1995年 | 556篇 |
1994年 | 449篇 |
1993年 | 356篇 |
1992年 | 476篇 |
1991年 | 382篇 |
1990年 | 399篇 |
1989年 | 397篇 |
1988年 | 365篇 |
1987年 | 319篇 |
1986年 | 275篇 |
1985年 | 253篇 |
1984年 | 215篇 |
1983年 | 200篇 |
1982年 | 161篇 |
1981年 | 138篇 |
1980年 | 114篇 |
1979年 | 156篇 |
1978年 | 114篇 |
1977年 | 108篇 |
1975年 | 86篇 |
1974年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
David W. Farley DDS John D. Jones DDS Robert J. Cronin DDS MS 《Journal of prosthodontics》1998,7(2):84-90
Phonetics, esthetics, function, and comfort form the foundation of a successful dental prosthesis. A review of the mechanics of speech as well as common speech problems encountered with a removable maxillary prosthesis are presented. The use of a palatogram to aid the clinician in the assessment and resolution of speech problems associated with a maxillary denture is demonstrated. 相似文献
52.
Robert K.P Chow MD Vincent C Ho MD FRCPC 《Journal of the American Academy of Dermatology》1996,34(6):1047-1060
Critical to the proper management of pyoderma gangrenosum are correct diagnosis, identification and treatment of any underlying disorder, and the proper choice of topical and systemic therapy. Many agents are available for the treatment of pyoderma gangrenosum. We review the current therapeutic options, their efficacy and side effects, and we offer some guidelines for their proper selection. 相似文献
53.
54.
Jin Woo Kim M.D. Ho Shik Kim M.D. In Kyung Kim M.D. Mee Ran Kim M.D. Eun Young Cho B.S. Heung Kee Kim M.D. Joon Mo Lee M.D. Sung Eun Namkoong M.D. 《Gynecologic oncology》1998,69(3):230-236
Transforming growth factor-β1 (TGF-β1) is known to be a potent growth inhibitor for many cell types, including most epithelial cells. In skin keratinocytes, TGF-β1 has been shown to inhibit growth and to rapidly reduce c-mycexpression. However, the molecular mechanism of TGF-β1 action on cell growth of cervical carcinoma has not yet been elucidated. We thus assessed the effect of TGF-β1 on the growth of cervical carcinoma cell lines. Two cervical squamous carcinoma cell lines, CUMC-3 and CUMC-6, were incubated with varying concentrations of TGF-β1, and growth inhibition was evaluated with tetrazolium-based colorimetric assay. After culture in TGF-β1 for 24 h, inhibition of growth was detected in a dose-dependent manner at concentrations of 0.1–10 ng/ml in both cell lines. This effect of TGF-β1 on cultured carcinoma cells was associated with apoptotic process including oligonucleosomal ladder DNA and apoptotic body formations. Northern blot analysis revealed c-mycmRNA expression was suppressed by 10 ng/ml of TGF-β1 following 3 h of treatment in both cell lines. Western blot analysis showed that the level of p27Kip1protein was increased after TGF-β1 treatment in both cell lines. These results suggest that the mechanisms by which TGF-β1 inhibits the growth of cervical carcinoma are complex and may include effects on down-regulation of c-mycgene, and overexpression of p27Kip1protein. 相似文献
55.
56.
Purpose. To determine whether the non-toxic pentameric B subunit of Cholera toxin (CTB) binding to ganglioside GM1 on both the lipid vesicles and epithelial cells may provide a means to target lipid vesicles to mucosal cells expressing surface GM1.
Methods. Sonicated lipid vesicles containing ganglioside GM1 were prepared. Inter-vesicle cross-linking due to pentameric CTB binding to these GM1 vesicles was determined with a sub-micron particle analyzer. Association of CTB to GM1 vesicles was analyzed with continuous sucrose gradient centrifugation. CTB-mediated binding of GM1 vesicles to human mucosal epithelial cells (Caco-2 and HT-29), mucous membranes of mouse trachea, and nasal tissues were detected with fluorescent labeled vesicles.
Results. An increase in lipid particle size due to binding of CTB to lipid vesicles and inter-vesicles cross-linking was detected. At a 30-to-1 mole ratio of membrane-bound GMl-to-CTB, optimum increase in GM1 vesicle aggregation, was detected. Under such conditions, all the added CTB molecules were associated with GM1 vesicles. Time course analysis showed that inter-vesicles cross linking by CTB was detectable within 10 min. and reached a maximum value at 60 min. CTB associated GM1-vesicles bind to mucosal epithelial cells HT-29 and Caco-2 with similar affinity [Kd = 7.8 × 10–4 M lipid (Caco-2) and 7.6 × 10–4 M lipid (HT-29)]. GM1 mediated binding specificity was demonstrated by blocking with anti-GMl antibody and the insignificant degree of CTB-associated GM1 vesicle binding to GM1 deficient C6 cells.
Conclusions. The CTB-mediated GM1 binding to multiple membrane surfaces provides selective localization of GM1 vesicles to GM1 expressing mucosal cells and tissues. The strategy may be useful in localizing drugs and proteins to gut and respiratory tract mucosa. 相似文献
57.
58.
59.
60.